ImageneBio, Inc. (IMA) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$47.84M | -124.4% |
| 2024 | -$21.32M | +73.3% |
| 2023 | -$79.74M | -7.6% |
| 2022 | -$74.11M | -23.0% |
| 2021 | -$60.25M | -59.3% |
| 2020 | -$37.83M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$47.84M | -124.4% |
| 2024 | -$21.32M | +73.3% |
| 2023 | -$79.74M | -7.6% |
| 2022 | -$74.11M | -23.0% |
| 2021 | -$60.25M | -59.3% |
| 2020 | -$37.83M | — |